首页> 外文会议>International Nanoscience and Nanotechnology Symposium >Effects of Microemulsion Preparation Conditions on Drug Encapsulation Efficiency of PLGA Nanoparticles
【24h】

Effects of Microemulsion Preparation Conditions on Drug Encapsulation Efficiency of PLGA Nanoparticles

机译:微乳液制备条件对PLGA纳米粒子药物包封效率的影响

获取原文

摘要

Emulsion solvent evaporation technique is widely used to prepare nanoparticles of many organic polymer drug carriers. The mechanism of nanoparticle generation by this technique involves oil-in-water (O/W) microemulsion formation followed by solvent evaporation. Various microemulsion preparation conditions can affect the encapsulation efficiency of drug in the nanoparticulate carrier. In this study, emulsifying speed, emulsifying temperature, and organic-to-aqueous phase ratio were varied and the resulting encapsulation efficiency of a model drug in Poly(Lactide-co-Glycolide) (PLGA) nanoparticles was determined. The organic phase containing PLGA and a model drug dissolved in chloroform was first dispersed in an aqueous solution containing 0.5 %(w/v) Poly(vinyl alcohol) (PVA), which was then homogenized at high speeds. The resulting O/W microemulsion was subsequently subjected to stirring at room temperature for four hours during which the solvent diffused and evaporated gradually. The fine white suspension was centrifuged and freeze-dried. The model drug loading in the PLGA nanoparticles was determined using UV spectrophotometry. Results showed that the encapsulation efficiency of a model drug, salicylic acid, ranged from 8.5% to 17% depending on the microemulsion preparation conditions. Under the same temperature (15 °C) and homogenization speed (19000 rpm) conditions studied, a relatively high organic-to-aqueous phase ratio (1:5) provided salicylic acid loaded PLGA nanoparticles with significantly higher drug encapsulation efficiency. In addition, under all microemulsion preparation conditions, PLGA nanoparticles obtained after solvent evaporation and freeze drying were spherical and aggregation between the nanoparticles was not observed under a high power microscope. This indicates that PLGA nanoparticles with desirable amount of drug and with anticipated size and shape can be realized by controlling emulsification process conditions.
机译:乳液溶剂蒸发技术广泛用于制备许多有机聚合物药物载体的纳米颗粒。通过该技术的纳米粒子产生的机理涉及水 - 水(O / W)微乳液形成,然后溶剂蒸发。各种微乳液制备条件会影响纳米颗粒载体中药物的包封效率。在该研究中,改变乳化速度,乳化温度和有机 - 水相比,并测定了聚(丙交酯 - 共乙酰化)(PLGA)纳米颗粒中的模型药物的所得封装效率。含有PLGA的有机相和溶解在氯仿中的模型药物首先分散在含有0.5%(w / v)聚(乙烯醇)(PVA)的水溶液中,然后在高速均匀化。随后将得到的O / W微乳液在室温下搅拌4小时,在此期间溶剂逐渐扩散并蒸发。离心细白色悬浮液并冷冻干燥。使用紫外分光光度法测定PLGA纳米颗粒中的模型药物负载。结果表明,根据微乳液制备条件,模型药物,水杨酸的封装效率为8.5%至17%。在相同的温度(15℃)和所研究的均质化速度(19000rpm)条件下,相对高的有机 - 水相比(1:5)提供了具有显着提高药物包封效率的水杨酸负载的PLGA纳米颗粒。另外,在所有微乳液制备条件下,在溶剂蒸发和冷冻干燥后得到的PLGA纳米颗粒在高功率显微镜下未观察到纳米颗粒之间的球形和聚集。这表明通过控制乳化过程条件,可以实现具有所需药物和预期的药物和预期尺寸和形状的PLGA纳米颗粒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号